Gout is a painful joint disease affecting about five million people in the United States. Gout is a form of arthritis that is caused by a build-up of uric acid in the blood.
On Friday, the Food and Drug Administration approved Uloric (febuxostat) giving gout sufferers a new drug to treat their disease. It is the first new treatment for gout in over 40 years. The drug is produced by Takeda Pharmaceuticals North America, Inc.
Uloric works by blocking the enzyme xanthine oxidase and therefore reducing levels of blood uric acid. It is a once-daily drug.